4.09 Problems with the VISION Trial & Stool Transplant Plus Nivo for Metastatic Melanoma
- Author
- [email protected] (Vinay Prasad, MD MPH)
- Published
- Fri 23 Jul 2021
- Episode Link
- https://soundcloud.com/plenarysession/ep409
Today we have two short monologues for you on recent papers. The first, by popular request, is the problems with the VISION trial, which treated metastatic castration-resistant prostate cancer with lutetium-177–PSMA-617 (Lu-177–PSMA-617) radioligand therapy and standard of care. The second is on the paper recently published in Science titled "Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients".
Fecal transplant: doi.org/10.1126/science.abb5920
Back us on Patreon! www.patreon.com/plenarysession
Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew
